AbbVie (ABBV)

AbbVie (ABBV) Cash flow


AbbVie Cash Flow

ABBV's free cash flow for Q1 2023 was $1.95B. For the 2023 fiscal year, ABBV's free cash flow was decreased by $-492.00M and operating cash flow was $2.12B. See a summary of the company’s cash flow.
Cash Flow
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ 20.54B$ 22.19B$ 22.78B$ 17.59B$ 13.32B$ 13.43B
Investing Cash Flow
$ 4.46B$ 2.14B$ -2.34B$ -37.56B$ 596.00M$ -1.01B
Financing Cash Flow
$ -24.33B$ -24.80B$ -19.04B$ -11.50B$ 18.71B$ -14.40B
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 36.24B$ 9.21B$ 9.75B$ 8.45B$ 39.92B$ 7.29B
Income Tax Paid Supplemental Data
$ 2.99B$ 2.99B$ 3.65B$ 1.67B$ 1.45B-
Interest Paid Supplemental Data
$ 2.55B$ 2.55B$ 2.71B$ 2.62B$ 1.79B$ 1.22B
Issuance Of Capital Stock
Issuance Of Debt
$ -8.20B$ -12.43B$ 1.00B$ 3.00B$ 31.48B$ 9.26B
Repayment Of Debt
$ -10.90B$ -14.43B$ -9.41B$ -5.68B$ -5.24B$ -6.04B
Free Cash Flow
$ 19.83B$ 21.50B$ 21.99B$ 16.79B$ 12.77B$ 12.79B
Domestic Sales
Foreign Sales
Currency in USD

AbbVie Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis